"Myeloid Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The classes of BONE MARROW-derived blood cells in the monocytic series (MONOCYTES and their precursors) and granulocytic series (GRANULOCYTES and their precursors).
| Descriptor ID |
D022423
|
| MeSH Number(s) |
A11.627
|
| Concept/Terms |
Myeloid Cells- Myeloid Cells
- Cell, Myeloid
- Cells, Myeloid
- Myeloid Cell
|
Below are MeSH descriptors whose meaning is more general than "Myeloid Cells".
Below are MeSH descriptors whose meaning is more specific than "Myeloid Cells".
This graph shows the total number of publications written about "Myeloid Cells" by people in this website by year, and whether "Myeloid Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 1 | 2 |
| 2002 | 0 | 3 | 3 |
| 2003 | 0 | 2 | 2 |
| 2004 | 1 | 0 | 1 |
| 2005 | 2 | 0 | 2 |
| 2006 | 3 | 1 | 4 |
| 2007 | 1 | 5 | 6 |
| 2008 | 0 | 1 | 1 |
| 2009 | 2 | 0 | 2 |
| 2011 | 1 | 3 | 4 |
| 2012 | 4 | 5 | 9 |
| 2013 | 3 | 5 | 8 |
| 2014 | 8 | 3 | 11 |
| 2015 | 5 | 1 | 6 |
| 2016 | 2 | 6 | 8 |
| 2017 | 4 | 7 | 11 |
| 2018 | 0 | 8 | 8 |
| 2019 | 3 | 2 | 5 |
| 2020 | 4 | 6 | 10 |
| 2021 | 3 | 9 | 12 |
| 2022 | 2 | 5 | 7 |
| 2023 | 0 | 2 | 2 |
| 2024 | 2 | 4 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Myeloid Cells" by people in Profiles.
-
Solid tumour-induced systemic immunosuppression involves dichotomous myeloid-B cell interactions. Nat Cell Biol. 2024 Nov; 26(11):1971-1983.
-
Myeloid cells coordinately induce glioma cell-intrinsic and cell-extrinsic pathways for chemoresistance via GP130 signaling. Cell Rep Med. 2024 Aug 20; 5(8):101658.
-
TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoint therapy in pancreatic cancer. Nat Commun. 2024 Jul 10; 15(1):5291.
-
Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma. Neuro Oncol. 2024 May 03; 26(5):826-839.
-
Spectral Flow Cytometry Methods and Pipelines for Comprehensive Immunoprofiling of Human Peripheral Blood and Bone Marrow. Cancer Res Commun. 2024 Mar 25; 4(3):895-910.
-
CADHERIN-11 regulation of myeloid phagocytes and autoimmune inflammation in murine lupus. J Autoimmun. 2024 May; 145:103197.
-
LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy. Cancer Res. 2023 12 15; 83(24):4047-4062.
-
Circulating senescent myeloid cells infiltrate the brain and cause neurodegeneration in histiocytic disorders. Immunity. 2023 Dec 12; 56(12):2790-2802.e6.
-
Characterization of Chemotaxis-Associated Gene Dysregulation in Myeloid Cell Populations in the Lungs during Lipopolysaccharide-Mediated Acute Lung Injury. J Immunol. 2023 06 15; 210(12):2016-2028.
-
Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer. Nat Cancer. 2023 01; 4(1):62-80.